Mirae Asset Global Etfs Holdings Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 47,183 shares of LXRX stock, worth $59,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,183Holding current value
$59,922% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
131Shares Held
240MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4175MShares$222 Million18.64% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$12.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$10.5 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$9.75 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.85MShares$7.42 Million0.24% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $240M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...